Image: Graphic of tumorcells; Copyright: panthermedia.net/Vitanovski

Tumor cells are dependent on fat to start metastasis

08/12/2016

A study headed by Salvador Aznar Benitah, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona), and published today in Nature identifies metastasis-initiating cells through a specific marker, namely the protein CD36. This protein, which is found in the membranes of tumour cells, is responsible for taking up fatty acids.
Read more
Photo: Child gets pierced into the finger using a lancing device

Diabetes: comprehensive prevention, early "vaccination"?

08/04/2016

A diagnosis of diabetes often catches new patients off guard - for instance if they end up in the emergency room suffering from metabolic decompensation. Children are often affected by this. Their immune system destroys the insulin-producing cells in the pancreas early on in their lives, thus causing type 1 diabetes.
Read more
Photo: Old woman with a smartphone

Health Apps: "Mobile Applications for smartphones have strengths and weaknesses"

22/03/2016

Medical apps like diabetes or high blood pressure diaries are becoming increasingly popular with smartphone users. There are many available choices out there but they are not always clear. Added to this is the question of how the data collected by the apps can be sensibly incorporated into treatment.
Read more
Graphic: The pancreas and the surrounding organs

Pancreatic cancer: diagnosis via signature analysis

08/03/2016

Pancreatic cancer is one of the deadliest forms of cancer because it is difficult to diagnose and only presents with symptoms in the later stages. In the future, a laboratory test developed at the Greifswald University Medicine could make an early detection of this type of cancer and consequently a faster and better treatment possible.
Read more
Photo: Small POC test kit for blood samples; Copyright: bate-web/Spelleken

Nutrition: finding intolerances in the blood

27/11/2015

More and more people suffer from allergies and food intolerances. Laboratory diagnosis for these often takes long and can be inaccurate. Healthcare practitioners increasingly rely on point-of-care tests to avoid costly laboratory tests and quickly find solutions for their patients.
Read more

Theranostics: Complex particles for tomorrow's medicine

01/10/2015

It is a portmanteau, a mixture of two words. This way it saves us time and trouble while speaking because the human speech apparatus is lazy. And it describes a mixture of procedures: the combination of two procedures that would normally be separate in medicine. We are talking about theranostics.
Read more

Small companions: How wearables change our lives

01/09/2015

They can be seen everywhere: at the wrists, in the ear, clipped to the belt. Wearables are small technical assistants who are built to collect and partially also to analyze data. Some of them collect measurable health data, others "only" count their user’s steps or measure the surrounding UV radiation. The fact is, however, that wearables are en vogue and are used for many different cases.
Read more

Prostate cancer: Agent with theranostic potential

03/08/2015

Endoradiotherapy can be very unpleasant for cancer patients, since it does not only harm tumor cells, but also healthy ones. Sometimes, patients even need to stop therapy because of the side effects. Physicians and researchers are thus continuously searching for ways to transport radiopharmaceuticals directly and exclusively to their target.
Read more

Cancer Immunotherapy: Individual mutations as new target structures

01/06/2015

A tumor is as unique as the person who is affected by it. For a long time, it was assumed this would make treatment more difficult since cancer drugs are not able to be one hundred percent effective in targeting the affected cells. In this interview with MEDICA.de, Professor Ugur Sahin explains why it is precisely these individual mutations that make him hopeful for a new type of therapy.
Read more

Lung cancer: A blood test evaluates the effectiveness of therapy

01/06/2015

Can liquid biopsies become the new trend in cancer diagnostics? The medical world has asked this question for quite some time. The first globally approved liquid biopsy-based test for lung cancer shows that this can work. Yet further findings and research are still required to establish this less invasive method in diagnostics.
Read more

Tumor markers: State-of-the-art diagnostics for personalized medicine

01/06/2015

When cancer is diagnosed, the terms tumor markers or biomarkers keep popping up. They describe characteristics that are not found in healthy persons. The classic tumor markers can be easily detected in blood samples or other body fluids. Other analysis methods require more effort. Yet they all share one thing in common: biomarkers indicate a potential tumor.
Read more
Photo: Object slides

Tissue storage: "Our top biobanks are internationally leading the charge"

02/02/2015

Only projects with a solid foundation are successful in the long run. This is also true for science. Biobanks are the most important component of this foundation when it comes to fundamental biomedical research: Only high quality tissue samples that are stored there make conclusive research possible - for example in search of the causes of tumorigenesis.
Read more